B · Normal
[Pakistan makes preliminary anti-dumping ruling on China-related ibuprofen] On October 19th, the National Tariff Commission of Pakistan issued the latest announcement on Case No. ADC78 on October 15, 2026, making a positive preliminary anti-dumping ruling on ibuprofen originating in or imported from China and the United States. The preliminary ruling was to impose temporary anti-dumping duties on the products involved. Among them, the tax rate for the products involved in China is 8.71%, and the tax rate for the products involved in the United States is 7.77%. The measures will take effect from the date of the announcement and will be valid for four months. The Pakistani tax number of the product involved is 2916.3910. The final ruling in this case is expected to be made within 180 days from the date of release of the preliminary ruling. On July 25, 2026, Pakistan launched an anti-dumping investigation into ibuprofen originating in or imported from China and the United States. The dumping investigation period of the case is from April 1, 2025 to March 31, 2026, and the damage investigation period is from April 1, 2023 to March 31, 2026.
Comments